Pharmaceutical microbiology is a specialized field within the pharmaceutical industry that focuses on the study of microorganisms and their impact on the production and quality of pharmaceutical products. Microorganisms, such as bacteria, fungi, viruses, and parasites, can pose significant challenges to the manufacturing process and the safety of pharmaceuticals.
One critical aspect of pharmaceutical microbiology is ensuring the sterility of pharmaceutical products, especially injectable medications and other sterile formulations. Microbial limits testing is essential procedure that establishes the acceptable levels of microbial contamination in non-sterile pharmaceuticals.
In addition to quality control measures, pharmaceutical microbiologists play a crucial role in monitoring and maintaining the cleanliness of manufacturing facilities. Environmental monitoring involves regularly testing the air, surfaces, and personnel for microbial contamination to prevent the introduction of harmful microorganisms during the production process.
The field of pharmaceutical microbiology is dynamic, evolving to address emerging challenges such as antimicrobial resistance and the development of microbiome-based therapies. By integrating microbiological principles into pharmaceutical practices, this discipline ensures the production of safe and effective medications for global healthcare.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil